Please login to the form below

Not currently logged in
Email:
Password:

Complaints about UK medical advertising drop

And this year the MHRA will be vetting adverts to promote a ‘right first time’ approach

mhra logoThe Medicines and Healthcare products Regulatory Agency (MHRA)'s annual medical advertising report shows a decrease in complaints received last year.

Although complaints dropped to 193, down from 283 from the previous year, the report entitled 'Delivering high standards in medicines advertising' detailed serious breaches in regulations by healthcare bodies.

Johnson & Johnson filed a complaint to the MHRA concerning a TV advertisement produced by Omega Pharma for Bronchostop, a traditional herbal medicine licensed on the basis of evidence of traditional usage that wrongly suggesting the efficacy of the treatment had been demonstrated.

Another complaint lodged to the MHRA cited a meeting for healthcare professionals, where medicines were promoted and attendees were expected to make a 'minimum' purchase, which is not in line with the law.

Beryl Keeley, head of the MHRA's advertising standards unit, commented: “People have the right to know that the advertisements they see are accurate and do not contain any information that could be misleading and that is why we and the self-regulatory bodies take the action that we do.

“In the coming year, we expect to vet advertising for around 50 products to promote a 'right first time' approach and protect against misleading messages in advertising.”

Complaints to the MHRA are resolved through voluntary agreements, by companies either correcting or removing their adverts without the need for further regulatory action.

Article by
Kirstie Pickering

3rd March 2015

From: Marketing, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics